Detection of interferon alpha protein reveals differential levels and cellular sources in disease

AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies

(2016) Steffen Meyer et al.   CELL

Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease

(2016) Gillian I. Rice et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview

(2016) Mathieu P. Rodero et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus

(2016) Stewart J. Wiseman et al.   STROKE

ID: 2

(2015) Curdin Conrad et al.   CYTOKINE

Thrombotic Microangiopathy Associated with Interferon Beta

(2014) David Hunt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study

(2013) Gillian I Rice et al.   LANCET NEUROLOGY

Type I interferon blockade in systemic lupus erythematosus: where do we stand?

(2013) B. R. Lauwerys et al.   RHEUMATOLOGY

Type I interferonopathies: a novel set of inborn errors of immunity

(2011) Yanick J. Crow   Annals of the New York Academy of Sciences

Evolutionary genetic dissection of human interferons

(2011) Jérémy Manry et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon

(2011) Marianne Berger Rentsch et al.   PLoS One

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY

Monocyte surface expression of Fcγ receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus

(2010) Yi Li et al.   ARTHRITIS RESEARCH & THERAPY

Elevated serum interferon-α activity in juvenile dermatomyositis: Associations with disease activity at diagnosis and after thirty-six months of therapy

(2009) Timothy B. Niewold et al.   ARTHRITIS AND RHEUMATISM

Validation of a HeLa Mx2/Luc Reporter Cell Line for the Quantification of Human Type I Interferons

(2009) Young-Jun Seo et al.   PHARMACOLOGY